Knappskog, S., Chrisanthar, R., Løkkevik, E., Anker, G., Østenstad, B., Lundgren, S., . . . Lønning, P. E. (2012). Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer. BioMed Central.
Trích dẫn kiểu ChicagoKnappskog, Stian, et al. Low Expression Levels of ATM May Substitute for CHEK2 /TP53 Mutations Predicting Resistance Towards Anthracycline and Mitomycin Chemotherapy in Breast Cancer. BioMed Central, 2012.
Trích dẫn MLAKnappskog, Stian, et al. Low Expression Levels of ATM May Substitute for CHEK2 /TP53 Mutations Predicting Resistance Towards Anthracycline and Mitomycin Chemotherapy in Breast Cancer. BioMed Central, 2012.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.